TRUALT TruAlt Bioenergy Q1 FY27 results (Apr–Jun 2026) and concall
TruAlt Bioenergy Limited reported a strong Q1 FY27, with significant revenue and profit growth driven by improved ethanol production and dual-feed plant operations. The company achieved an EBITDA margin of 23.5% and PAT margin of 9.5%. Expansion in the Compressed Biogas (CBG) and Sustainable Aviation Fuel (SAF) verticals is underway, supported by JVs and government funding, though full ethanol capacity utilization and green hydrogen progress face challenges.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
Q1 FY27: revenue up 106.3%, net profit up 1080.0% against the same quarter last year.
| Line item | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 |
|---|---|---|---|---|---|---|---|
| Revenue | 415 | 907 | 304 | 115 | 713 +72% | 596 −34% | 627 +106% |
| EBITDA | 125 | 154 | 42 | -5 | 134 +7% | 129 −16% | 133 +217% |
| Net profit | 75 | 112 | 5 | -38 | 69 −8% | 69 −38% | 59 +1080% |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.





